Sandwich-Type Au-PEI/DNA/PEI-Dexa Nanocomplex for Nucleus-Targeted Gene Delivery in Vitro and in Vivo
Source abstract
Abstract
Many synthetic Au-based cationic nanoparticles (AuNPs) for nonviral gene delivery show high efficiency in vitro, but their excessive charge density, harsh reducing conditions, and nontarget delivery prevent their application in vivo. Herein, we constructed a sandwich-type layered polyethylenimine (PEI)-coated gold nanocomposite outerlaid with a nucleus-targeted Dexamethasone (Dexa), namely, Au-PEI/DNA/PEI-Dexa nanocomplex, for DNA delivery system using a low molecular weight PEI as a mild reducing agent. The nucleus-targeting Au-PEI/DNA/PEI-Dexa nanocomplex with low positive charge and low cytotoxicity condensed DNA and protected from enzymatic degradation. In vitro transfection studies demonstrated that Au-PEI/DNA/PEI-Dexa nanocomplex exhibited much more efficient nucleus transfection than Au-PEI/DNA/PEI without nucleus-targeted residues and commercially available PEI 25 kDa due to the Dexa targeting of the nucleus. Furthermore, the nanocomplex markedly transfected pTRAIL (TRAIL = tumor-necrosis-factor-related apoptosis-inducing ligand) to tumors in vivo and subsequently inhibited the tumor growth with minimal side effects. These findings suggest that nucleus-targeting Au-PEI/DNA/PEI-Dexa ternary complexes have promising potential in gene delivery.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: RNA Interference and Gene Delivery · Advanced biosensing and bioanalysis techniques · Graphene and Nanomaterials Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
State Key Laboratory of Applied Organic Chemistry, Key Laboratory of Nonferrous Metals Chemistry and Resources Utilization of Gansu Province, College of Chemistry and Chemical Engineering, Institute of Biochemical Engineering & Environmental Technology, Lanzhou University, Lanzhou 730000, China
Funding
National Natural Science Foundation of China · Fundamental Research Funds for the Central Universities · Youth Science Foundation of Gansu Province
References (40)
Show source-provided references
1. Corsi K. · Biomaterials · 2003 · 24 · 125510.1016/S0142-9612(02)00507-0 ↗
2. Cebrian V. · Acta Biomater. · 2011 · 7 · 364510.1016/j.actbio.2011.06.018 ↗
3. Pack D. W. · Nat. Rev. Drug Discovery · 2005 · 4 · 58110.1038/nrd1775 ↗
4. Read, M. L.; Logan, A.; Seymour, L. W.InNon-Viral Vectors for Gene Therapy,2nd ed;Huang, L.; Hung, M.; Wagner, E., Eds.Elsevier:San Diego, CA, 2005; Part 1, Vol53, pp19–46.10.1016/S0065-2660(05)53002-5 ↗
5. Ogris M. · J. Controlled Release · 2003 · 91 · 17310.1016/S0168-3659(03)00230-X ↗
6. Chabaud P. · Bioconjugate Chem. · 2006 · 17 · 46610.1021/bc050162q ↗
7. Malhotra M. · Biomaterials · 2013 · 34 · 127010.1016/j.biomaterials.2012.10.013 ↗
8. Wood K. C. · Angew. Chem., Int. Ed. · 2005 · 44 · 670410.1002/anie.200502152 ↗
9. Li S. · Gene Ther. · 2000 · 7 · 3110.1038/sj.gt.3301110 ↗
10. Merdan T. · Adv. Drug Delivery Rev. · 2002 · 54 · 71510.1016/S0169-409X(02)00046-7 ↗
11. Peng Z. · PloS One · 2014 · 9 · e9292410.1371/journal.pone.0092924 ↗
12. Boyer C. · J. Mater. Chem. · 2010 · 20 · 25510.1039/B914063H ↗
13. Rosi N. L. · Science · 2006 · 312 · 102710.1126/science.1125559 ↗
14. Xu C. · ACS Appl. Mater. Interfaces · 2013 · 5 · 271510.1021/am400212j ↗
15. Gemeinhart R. A. · Biotechnol. Prog. · 2005 · 21 · 53210.1021/bp049648w ↗
16. Boisselier E. · Chem. Soc. Rev. · 2009 · 38 · 175910.1039/b806051g ↗
17. Ghosh P. · Adv. Drug Delivery Rev. · 2008 · 60 · 130710.1016/j.addr.2008.03.016 ↗
18. Giljohann D. A. · Angew. Chem., Int. Ed. · 2010 · 49 · 328010.1002/anie.200904359 ↗
19. Ghosh P. S. · ACS Nano · 2008 · 2 · 221310.1021/nn800507t ↗
20. Thomas M. · Proc. Natl. Acad. Sci. U.S.A. · 2003 · 100 · 913810.1073/pnas.1233634100 ↗
21. Sandhu K. K. · Bioconjugate Chem. · 2002 · 13 · 310.1021/bc015545c ↗
22. Niidome T. · Chem. Commun. · 2004 · 197810.1039/b406189f ↗
23. Li P. C. · Biomaterials · 2008 · 29 · 361710.1016/j.biomaterials.2008.05.020 ↗
24. Boussif O. · Proc. Natl. Acad. Sci. U.S.A. · 1995 · 92 · 729710.1073/pnas.92.16.7297 ↗
25. Godbey W. T. · Proc. Natl. Acad. Sci. U.S.A. · 1999 · 96 · 517710.1073/pnas.96.9.5177 ↗
26. Hu C. · Bioconjugate Chem. · 2010 · 21 · 83610.1021/bc900374d ↗
27. Chen S. · Mol. BioSyst. · 2011 · 7 · 284110.1039/c1mb05147d ↗
28. Nishikawa M. · Hum. Gene Ther. · 2001 · 12 · 86110.1089/104303401750195836 ↗
29. Adcock I. M. · Immunol. Cell Biol. · 2001 · 79 · 37610.1046/j.1440-1711.2001.01025.x ↗
30. Shahin V. · J. Cell. Physiol. · 2005 · 202 · 59110.1002/jcp.20152 ↗
31. Sun X. · J. Colloid Interface Sci. · 2005 · 288 · 30110.1016/j.jcis.2005.02.079 ↗
32. Godbey W. T. · J. Controlled Release · 1999 · 60 · 14910.1016/S0168-3659(99)00090-5 ↗
33. Elbashir S. M. · Nature · 2001 · 411 · 49410.1038/35078107 ↗
34. Qin X. F. · Proc. Natl. Acad. Sci. U.S.A. · 2003 · 100 · 18310.1073/pnas.232688199 ↗
35. Schmalenberg K. E. · Biomacromolecules · 2001 · 2 · 85110.1021/bm010042v ↗
36. Sonawane N. D. · J. Biol. Chem. · 2003 · 278 · 4482610.1074/jbc.M308643200 ↗
37. Ashkenazi A. · Science · 1998 · 281 · 130510.1126/science.281.5381.1305 ↗
38. Ashkenazi A. · J. Clin. Invest. · 1999 · 104 · 15510.1172/JCI6926 ↗
39. Zhou J. B. · Nat. Mater. · 2012 · 11 · 8210.1038/nmat3187 ↗
40. Kagawa S. · Cancer Res. · 2001 · 61 · 3330